par Jacobs, Frédérique
;Selleslag, Dominik;Aoun, Michel
;Sonet, Alexis
;Gadisseur, A
Référence European journal of clinical microbiology & infectious diseases, 31, 6, page (1173-1179)
Publication Publié, 2012-06



Référence European journal of clinical microbiology & infectious diseases, 31, 6, page (1173-1179)
Publication Publié, 2012-06
Article révisé par les pairs
Titre: |
|
Auteur: | Jacobs, Frédérique; Selleslag, Dominik; Aoun, Michel; Sonet, Alexis; Gadisseur, A |
Informations sur la publication: | European journal of clinical microbiology & infectious diseases, 31, 6, page (1173-1179) |
Statut de publication: | Publié, 2012-06 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adolescent |
Adult | |
Aged | |
Aged, 80 and over | |
Antifungal Agents -- administration & dosage -- adverse effects | |
Aspergillosis -- drug therapy -- mortality | |
Drug Toxicity -- epidemiology | |
Female | |
Humans | |
Male | |
Middle Aged | |
Prospective Studies | |
Pyrimidines -- administration & dosage -- adverse effects | |
Survival Analysis | |
Time Factors | |
Treatment Outcome | |
Triazoles -- administration & dosage -- adverse effects | |
Young Adult | |
Note générale: | Journal Article |
Multicenter Study | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0934-9723 |
info:doi/10.1007/s10096-011-1425-5 | |
info:scp/84863846189 | |
info:pmid/21971820 | |
PMC3346940 |